Volume 8 Issue 3
May  2017
Turn off MathJax
Article Contents
He Tenghui, Qian Yeyong, Fan Yu, et al. Analysis of risk factors of herpes zoster after renal transplantation in a single center[J]. ORGAN TRANSPLANTATION, 2017, 8(3): 215-219. doi: 10.3969/j.issn.1674-7445.2017.03.008
Citation: He Tenghui, Qian Yeyong, Fan Yu, et al. Analysis of risk factors of herpes zoster after renal transplantation in a single center[J]. ORGAN TRANSPLANTATION, 2017, 8(3): 215-219. doi: 10.3969/j.issn.1674-7445.2017.03.008

Analysis of risk factors of herpes zoster after renal transplantation in a single center

doi: 10.3969/j.issn.1674-7445.2017.03.008
More Information
  • Corresponding author: Qian Yeyong, Email:qianyy@medmail.com.cn
  • Received Date: 2017-03-30
    Available Online: 2021-01-19
  • Publish Date: 2017-05-15
  •   Objective  To investigate the clinical characteristics and risk factors of the incidence of herpes zoster after renal transplantation.  Methods  Clinical data of 830 recipients undergoing renal transplantation for the first time in the Organ Transplantation Research Institute of the 309th Hospital of Chinese People's Liberation Army from March 2009 to March 2012 were retrospectively analyzed. Univariate and multivariate Logistic regression analyses were performed to identify the risk factors of the incidence of herpes zoster after renal transplantation.  Results  Among 830 patients, 42 (5.1%) suffered from herpes zoster postoperatively. Clinical manifestations of herpes zoster mainly included varicella-zoster rash in the head, face, trunk and limbs. No patient died from herpes zoster. Post-herpetic neuralgia (PHN) was the most common complication of herpes zoster. Univariate Logistic regression analysis revealed that advanced age and adrenal cortical hormone (hormone) shock therapy could increase the risk of herpes zoster viral infection after renal transplantation (OR=2.414, P=0.016; OR=2.936, P=0.003). Multivariate Logistic regression analysis demonstrated that advanced age and hormone shock therapy were the independent risk factor of the incidence of herpes zoster following renal transplantation (OR=2.238, P=0.030; OR=2.755, P=0.005).  Conclusions  Herpes zoster after renal transplantation is clinically manifested with varicella-zoster rash. Advanced age and hormone shock therapy are the independent risk factor of the incidence of herpes zoster after renal transplantation.

     

  • loading
  • [1]
    Kırnap M, Akdur A, Ayvazoğlu Soy HE, et al. Prevalence and outcome of herpes zoster infection in renal transplant recipients[J]. Exp Clin Transplant, 2015, 13(Suppl 1): 280-283. DOI: 10.6002/ect.mesot2014.P113.
    [2]
    Pergam SA, Forsberg CW, Boeckh MJ, et al. Herpes zoster incidence in a multicenter cohort of solid organ transplant recipients[J]. Transpl Infect Dis, 2011, 13(1): 15-23. DOI: 10.1111/j.1399-3062.2010.00547.x.
    [3]
    Koo S, Gagne LS, Lee P, et al. Incidence and risk factors for herpes zoster following heart transplantation[J]. Transpl Infect Dis, 2014, 16(1): 17-25. DOI: 10.1111/tid.12149.
    [4]
    Zuckerman RA, Limaye AP. Varicella zoster virus (VZV) and herpes simplex virus (HSV) in solid organ transplant patients[J]. Am J Transplant, 2013, 13(Suppl 3):55-66;quiz 66. DOI:10.1111/ajt.12003.
    [5]
    Johnson RW, Bouhassira D, Kassianos G, et al. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life[J]. BMC Med, 2010, 8: 37. DOI: 10.1186/1741-7015-8-37.
    [6]
    Ko GB, Kim T, Kim SH, et al. Increased incidence of herpes zoster in the setting of cytomegalovirus preemptive therapy after kidney transplantation[J]. Transpl Infect Dis, 2013, 15(4): 416-423. DOI: 10.1111/tid.12091.
    [7]
    Martin-Gandul C, Stampf S, Héquet D, et al. Preventive strategies against cytomegalovirus and incidence of alpha-herpesvirus infections in solid organ transplant recipients: a nationwide cohort study[J]. Am J Transplant, 2016, DOI:10.1111/ajt.14192[Epubahead of print].
    [8]
    Gourishankar S, Mcdermid JC, Jhangri GS, et al. Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era[J]. Am J Transplant, 2004, 4(1): 108-115. doi: 10.1046/j.1600-6143.2003.00287.x
    [9]
    Piaserico S, Sandini E, Peserico A, et al. Cutaneous viral infections in organ transplant patients[J]. G Ital Dermatol Venereol, 2014, 149(4): 409-415. http://www.minervamedica.it/it/riviste/dermatologia-venereologia/articolo.php?cod=R23Y2014N04A0409
    [10]
    Rommelaere M, Maréchal C, Yombi JC, et al. Disseminated varicella zoster virus infection in adult renal transplant recipients: outcome and risk factors[J]. Transplant Proc, 2012, 44(9): 2814-2817. DOI: 10.1016/j.transproceed.2012.09.090.
    [11]
    Pavlopoulou ID, Poulopoulou S, Melexopoulou C, et al. Incidence and risk factors of herpes zoster among adult renal transplant recipients receiving universal antiviral prophylaxis[J]. BMC Infect Dis, 2015, 15: 285. DOI: 10.1186/s12879-015-1038-1.
    [12]
    周海林, 蒋法兴.197例带状疱疹患者外周血T淋巴细胞亚群的测定[J].安徽医学, 2014, (4):485-487.DOI: 10.3969/j.issn.1000-0399.2014.04.024.

    Zhou HL, Jiang FX. Detection of peripheral blood T lymphocyte subsets in 197 cases with herpes zoster[J]. Anhui Med J, 2014(4):485-487. DOI: 10.3969/j.issn.1000-0399.2014.04.024.
    [13]
    Mustapic Z, Basic-Jukic N, Kes P, et al. Varicella zoster infection in renal transplant recipients: prevalence, complications and outcome[J]. Kidney Blood Press Res, 2011, 34(6): 382-386. DOI: 10.1159/000328730.
    [14]
    Hamaguchi Y, Mori A, Uemura T, et al. Incidence and risk factors for herpes zoster in patients undergoing liver transplantation[J]. Transpl Infect Dis, 2015, 17(5): 671-678. DOI: 10.1111/tid.12425.
    [15]
    蔡玲琴, 朱希聪, 张灵鹏, 等.急性期带状疱疹患者的临床特征与T细胞亚群的关系[J].中华全科医学, 2017, 15(1):39-41. DOI:10.16766 /j.cnki.issn.1674-4152.2017.01.012.

    Cai LQ, Zhou XC, Zhang LP, et al. Relationship of clinical features of acute herpes zoster with T cell subsets[J]. Chin J Gen Pract, 2017, 15(1):39-41. DOI:10.16766 /j.cnki.issn.1674-4152.2017.01.012.
    [16]
    Steain M, Sutherland JP, Rodriguez M, et al. Analysis of T cell responses during active varicella-zoster virus reactivation in human ganglia[J]. J Virol, 2014, 88(5): 2704-2716. DOI: 10.1128/JVI.03445-13.
    [17]
    Jantsch J, Schmidt B, Bardutzky J, et al. Lethal varicella-zoster virus reactivation without skin lesions following renal transplantation[J]. Nephrol Dial Transplant, 2011, 26(1):365-368. DOI: 10.1093/ndt/gfq542.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(2)

    Article Metrics

    Article views (223) PDF downloads(8) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return